BRPI0912106A2 - probióticos para melhorar a microbiota intestinal - Google Patents

probióticos para melhorar a microbiota intestinal

Info

Publication number
BRPI0912106A2
BRPI0912106A2 BRPI0912106A BRPI0912106A BRPI0912106A2 BR PI0912106 A2 BRPI0912106 A2 BR PI0912106A2 BR PI0912106 A BRPI0912106 A BR PI0912106A BR PI0912106 A BRPI0912106 A BR PI0912106A BR PI0912106 A2 BRPI0912106 A2 BR PI0912106A2
Authority
BR
Brazil
Prior art keywords
probiotics
intestinal microbiota
improve intestinal
improve
microbiota
Prior art date
Application number
BRPI0912106A
Other languages
English (en)
Inventor
Florence Rochat
Marie-Clarie Fichot
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08157010A external-priority patent/EP2127661A1/en
Priority claimed from EP08159900A external-priority patent/EP2143341A1/en
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0912106A2 publication Critical patent/BRPI0912106A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0912106A 2008-05-27 2009-05-12 probióticos para melhorar a microbiota intestinal BRPI0912106A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08157010A EP2127661A1 (en) 2008-05-27 2008-05-27 Probiotics to improve gut microbiotica
EP08159900A EP2143341A1 (en) 2008-07-08 2008-07-08 Nutritional Composition Containing Oligosaccharide Mixture
PCT/EP2009/055737 WO2009144137A1 (en) 2008-05-27 2009-05-12 Probiotics to improve gut microbiota

Publications (1)

Publication Number Publication Date
BRPI0912106A2 true BRPI0912106A2 (pt) 2015-10-13

Family

ID=40983519

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912106A BRPI0912106A2 (pt) 2008-05-27 2009-05-12 probióticos para melhorar a microbiota intestinal

Country Status (11)

Country Link
US (1) US20110064707A1 (pt)
EP (1) EP2303294A1 (pt)
CN (1) CN102065872A (pt)
AU (1) AU2009253281A1 (pt)
BR (1) BRPI0912106A2 (pt)
CA (1) CA2725051A1 (pt)
MX (1) MX2010012905A (pt)
RU (1) RU2010153257A (pt)
TW (1) TW201002216A (pt)
WO (1) WO2009144137A1 (pt)
ZA (1) ZA201009288B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397219B1 (it) * 2009-12-29 2013-01-04 Giuliani Spa Composizione farmaceutica o dietetica per il trattamento dell'atopia
CN102858191A (zh) * 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
WO2012140636A1 (en) * 2011-04-11 2012-10-18 Alimentary Health Limited A probiotic formulation
CA2839524C (en) 2011-06-20 2016-05-17 H.J. Heinz Company Probiotic compositions and methods
CN102690772B (zh) * 2012-06-15 2013-07-10 青岛蔚蓝生物集团有限公司 高活性复合乳酸菌饮料及其制备方法
DK3351554T3 (da) 2012-06-18 2021-08-30 Heinz Co Brands H J Llc Glutenrelaterede forstyrrelser
WO2013190531A1 (en) * 2012-06-22 2013-12-27 Glycom A/S Glycosylated galactosyl disaccharides, methods for their production and their use in consumable products
WO2013190529A1 (en) * 2012-06-22 2013-12-27 Glycom A/S Glycosylated galactosyl disaccharddes, methods for their production and their use in consumable products
ES2729641T3 (es) * 2013-05-10 2019-11-05 Heinz Co Brands H J Llc Probióticos y métodos de uso
AU2014368585A1 (en) * 2013-12-19 2016-05-19 Nestec S.A. Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
US10716816B2 (en) * 2014-10-24 2020-07-21 Evolve Biosystems Inc. Activated bifidobacteria and methods of use thereof
AU2015340605B2 (en) * 2014-10-29 2021-06-24 Biogaia Ab Use of L. reuteri for recovery of microbiota dysbiosis in early life
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
RU2724590C2 (ru) * 2015-08-04 2020-06-25 Сосьете Де Продюи Нестле С.А. Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
AU2016102461A6 (en) * 2015-08-04 2021-06-03 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
US11229659B2 (en) 2016-01-26 2022-01-25 Societe Des Produits Nestle S.A. Compositions with specific oligosaccharides to prevent or treat allergies
AU2017211273A1 (en) * 2016-01-26 2018-05-10 Société des Produits Nestlé S.A. Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic SCFA production and/or by increasing GLP-1 secretion
WO2017129642A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Composition for use in the prevention and/or treatment of skin conditions and skin diseases
CN108471793A (zh) * 2016-01-26 2018-08-31 雀巢产品技术援助有限公司 用于婴儿或幼儿以预防或治疗变态反应的包含人乳低聚糖的组合物
US20190160082A1 (en) * 2016-08-04 2019-05-30 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
CN109561723A (zh) * 2016-08-04 2019-04-02 雀巢产品技术援助有限公司 用于预防、治疗非轮状病毒相关性腹泻或降低其严重程度的包含低聚糖和任选地乳双歧杆菌的混合物的营养组合物和婴儿配方食品
US20200315235A1 (en) * 2016-10-05 2020-10-08 N. V. Nutricia Normalization of the Intestinal Microbiota Composition in Infants or Toddlers Fed with an Amino Acid-Based Nutritional Composition
EP4159224A1 (en) * 2017-06-30 2023-04-05 N.V. Nutricia Synbiotic composition for preventing chronic inflammation
MX2019014315A (es) * 2017-08-04 2020-02-03 Nestle Sa Bacterias probioticas preacondicionadas en un medio que contiene gos y uso de estas.
EP3646739A1 (en) * 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides
US20220000947A1 (en) * 2018-12-21 2022-01-06 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
AU2019407214B2 (en) * 2018-12-21 2025-04-24 Societe Des Produits Nestle S.A. A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier
PL3911341T3 (pl) * 2019-01-16 2023-05-02 N.V. Nutricia Fermentowany preparat z nieulegającymi trawieniu oligosacharydami do zastosowania w zakażeniu wywołanym przez rotawirusy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1993576T3 (pl) * 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna

Also Published As

Publication number Publication date
CA2725051A1 (en) 2009-12-03
ZA201009288B (en) 2012-06-27
US20110064707A1 (en) 2011-03-17
WO2009144137A1 (en) 2009-12-03
MX2010012905A (es) 2010-12-21
EP2303294A1 (en) 2011-04-06
CN102065872A (zh) 2011-05-18
AU2009253281A1 (en) 2009-12-03
RU2010153257A (ru) 2012-07-10
TW201002216A (en) 2010-01-16

Similar Documents

Publication Publication Date Title
NL301164I2 (nl) sacituzumab govitecan
ZA200907731B (en) Probiotics to improve gut microbiota
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
ZA201009288B (en) Probiotics to improve gut microbiota
PT2376107E (pt) Oligonucleotídeos imunoestimulantes
BRPI0914326A2 (pt) método para formar uma corrente de oxigênio quente
BRPI0817547A2 (pt) Método para realizar pirólise
DK2414531T3 (da) Forbedret biomasseforbehandlingsproces
EP2498885A4 (en) TOY KREISEL
ES2397671T8 (es) Procedimiento para preparar voriconazol
DK3311828T3 (da) Modificerede vasoaktive tarmpeptider
DK2428013T3 (da) Session push-overførsel
UA21012S (uk) Іграшка
FI20085767L (fi) Kipsituote
BRPI0913136A2 (pt) método para produzir uma peça e peça.
EP2495246A4 (en) FULLER DERIVATIVE
BRPI0925056A2 (pt) medicamento mastigável
EP2457898A4 (en) FULLER DERIVATIVE
BRPI0922653A2 (pt) preparação farmacêutica
BRPI0822797A2 (pt) Transmissão para uma máquina mecânica, e, máquina mecânica
BRPI1014912A2 (pt) linhagens bacterianas com uma notável capacidade para produzir menaquinona
BRPI0919102A2 (pt) vacinas de salmonella não-tifóide
EP2319520A4 (en) IMMUNOSTIMULATING MEDIUM
ES1070148Y (es) Macolla para barrotes mejorada
ES1068357Y (es) Estructura para seguidor solar

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A23L 33/135 (2016.01), A23L